Arsenal Biosciences (United States)
- Research works
- 39 fractional, all time
- Citations
- 764 19.5 per fractional work
- Top-10% rate
- 3.0% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Arsenal Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.5×. Every wedge is a field page.
Which keywords describe research at Arsenal Biosciences (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Monoclonal Antibodies and Glycosylation.
- Arginine Deprivation
- Tumor Targeting
- RNA Interference
- Biosensors
- NK Cell Recognition
- Immunogenicity
- Biosimilars
- Fc Receptors
- Glycosylation
- Lymphoma
- CAR T Cells
- Tumor Regression
- Immunotherapy
- Cancer Immunotherapy
- Chimeric Antigen Receptor
- Monoclonal Antibodies
- Gene Therapy
- Therapeutic Antibodies
- Genome Engineering
- RNA-Guided
- Natural Killer Cells
- Cell Culture
- siRNA Delivery
- Nanoparticles
- Bacterial Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Immunotherapy15▲ 60×3 topics
- Tumor Regression15▲ 385×2 topics
- Cancer Immunotherapy14▲ 264×2 topics
- CAR T Cells14▲ 533×1 topic
- Chimeric Antigen Receptor14▲ 533×1 topic
- Lymphoma14▲ 244×2 topics
- Monoclonal Antibodies5▲ 152×2 topics
- Glycosylation3▲ 87×2 topics
- Gene Therapy3▲ 39×3 topics
- Fc Receptors2▲ 131×1 topic
- Therapeutic Antibodies2▲ 103×1 topic
- Biosimilars2▲ 325×1 topic
- Genome Engineering2▲ 99×1 topic
- Immunogenicity2▲ 150×1 topic
- RNA-Guided2▲ 99×1 topic
- NK Cell Recognition2▲ 85×1 topic
- Natural Killer Cells2▲ 85×1 topic
- Biosensors2▲ 8.7×2 topics
- Cell Culture2▲ 39×2 topics
- RNA Interference2▲ 50×1 topic
- siRNA Delivery2▲ 72×1 topic
- Tumor Targeting1▲ 22×2 topics
- Nanoparticles1▲ 2.7×2 topics
- Arginine Deprivation1▲ 80×1 topic
- Bacterial Therapy1▲ 80×1 topic
Which research topics does Arsenal Biosciences (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Biosimilars and Bioanalytical Methods and CRISPR and Genetic Engineering.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 14 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 3 Biosimilars and Bioanalytical Methods Immunology 2 works
- 4 CRISPR and Genetic Engineering Molecular Biology 2 works
- 5 Immune Cell Function and Interaction Immunology 2 works
- 6 RNA Interference and Gene Delivery Molecular Biology 2 works
- 7 Cancer Research and Treatments Biotechnology 1 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 9 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Arsenal Biosciences (United States)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.